Table 1.
NC | HC | TE 500 | Sup 100 | Met 100 | |
---|---|---|---|---|---|
Serum | |||||
TG (g.L−1) | 0.36 ± 0.04 | 1.08 ± 0.05#### | 0.73 ± 0.04∗ | 0.41 ± 0.07∗∗∗∗ | 0.83 ± 0.11 |
Chol-T (g.L−1) | 1.29 ± 0.06 | 1.59 ± 0.13 | 1.55 ± 0.18 | 1.17 ± 0.07 | 1.18 ± 0.09 |
HDL-C (g.L−1) | 1.01 ± 0.05 | 0.92 ± 0.06 | 1.26 ± 0.10∗ | 1.10 ± 0.09 | 0.93 ± 0.03 |
LDL-C (g.L−1) | 0.28 ± 0.04 | 0.69 ± 0.11# | 0.36 ± 0.14 | 0.14 ± 0.04∗∗ | 0.23 ± 0.08∗ |
VLDL-C (mg.dL−1) |
7.2 ± 0.9 |
21.6 ± 1.1#### |
14.8 ± 1.0∗ |
8.2 ± 1.6∗∗∗∗ |
16.6 ± 2.2 |
Liver | |||||
TG (g.L−1) | 0.43 ± 0.04 | 1.15 ± 0.11#### | 0.49 ± 0.03∗∗∗∗ | 0.30 ± 0.03∗∗∗∗ | 0.67 ± 0.05∗∗∗ |
VLDL-C (mg.dL−1) | 9.26 ± 0.88 | 23.02 ± 2.37#### | 11.13 ± 1.28∗∗∗∗ | 5.26 ± 0.55∗∗∗∗ | 13.36 ± 1.05∗∗∗ |
The NC and HC groups received distilled water and the groups (TE 500, Sup 100 and Met 100) were treated respectively with total extract (500 mg.Kg−1), supernatant (100 mg.Kg−1) and metformin (100 mg.Kg−1) for 4 days. The results are treated with Anova one way and represent the mean ± ESM. ∗p < 0.05 ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001: Compared to hyperlipidemic control (HC); ####p < 0.0001; #p < 0.05: Compared to normal control (NC).